Goldman Sachs Group »

Oncolytics Biotech shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $89k 84k 1.06
2021-03-31 $39k 10k 3.79

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Ishares Tr CMN (IWM)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Vanguard Index Fds CMN (VOO)
Tesla CMN (TSLA)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Oncolytics Biotech

Morgan Stanley
International Assets Investment Management
Citadel Advisors
Goldman Sachs Group
Commonwealth Equity Services
Royal Bank of Canada
CIBC World Markets
Virtu Financial
Geode Capital Management
Millennium Management
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
LPL Financial

View all funds holding Oncolytics Biotech